Renaissance Technologies’s Stemline Therapeutics, Inc. STML Stock Holding History

Renaissance Technologies’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-158,213	Closed	-$766K	–	3928
2020 Q1	$766K	Buy	+158,213	New	+$1.03M	﹤0.01%	2555
2017 Q1	–	Sell	-65,500	Closed	-$701K	–	3505
2016 Q4	$701K	Buy	65,500 +4,800	+8%	+$58.1K	﹤0.01%	2669
2016 Q3	$657K	Buy	60,700 +7,800	+15%	+$63.4K	﹤0.01%	2731
2016 Q2	$358K	Sell	52,900 -26,200	-33%	-$165K	﹤0.01%	2898
2016 Q1	$369K	Buy	79,100 +10,500	+15%	+$51.3K	﹤0.01%	2929
2015 Q4	$433K	Buy	+68,600	New	+$557K	﹤0.01%	2783
2014 Q4	–	Sell	-99,300	Closed	-$1.24M	–	3198
2014 Q3	$1.24M	Sell	99,300 -1,752	-2%	-$21.6K	﹤0.01%	1920
2014 Q2	$1.48M	Buy	+101,052	New	+$1.55M	﹤0.01%	1880

Renaissance Technologies's STML Position: Q2 2020 in Review

Renaissance Technologies sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 158,213 shares — an estimated $766K sold.

Renaissance Technologies first reported a position in STML in Q2 2014 and held it in 8 quarters. The position peaked at $1.48M in Q2 2014. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Renaissance Technologies reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Renaissance Technologies sold 158,213 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $766K.
Renaissance Technologies first reported a position in Stemline Therapeutics, Inc. in Q2 2014 and held it in 8 quarters.
Renaissance Technologies's Stemline Therapeutics, Inc. position peaked at $1.48M in Q2 2014.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.